JPRN-UMIN000053078
Not yet recruiting
未知
A multicenter observational retrospective study of gemcitabine-plus alpha combination chemotherapy in patients with unresectable or recurrent biliary tract cancer (NAPOLEON BT Study) - NAPOLEON-BTS
Sasebo Kyosai Hospital0 sites500 target enrollmentDecember 12, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- nresectable or recurrent biliary tract cancer
- Sponsor
- Sasebo Kyosai Hospital
- Enrollment
- 500
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients 1\. with active double cancers. 2\. whom the doctor in\-chief judged not to be indicated for this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A multicenter retrospective observational study of effectiveness of mepolizumab in patients with severe eosinophilic asthma and comorbidities in Japan (J-Real-Mepo)JPRN-UMIN000045021Teikyo University School of Medicine200
Completed
Not Applicable
A multicenter retrospective observational study for pulmonary resection in pulmonary origometastasis after pancreatectomyPancreatic cancerJPRN-UMIN000046808Japan Oncology Network in Hepatobiliary and Pancreas120
Not yet recruiting
Not Applicable
A multicenter retrospective observational study to evaluate the efficacy and safety of durvalumab following concurrent chemoradiotherapy for stage III non-small cell lung cancer harboring EGFR mutation (NEJ063 study)on-small cell lung cancerJPRN-UMIN000051670Tohoku University Hospital300
Recruiting
Not Applicable
A multi-center retrospective observational study of effectiveness, safety and treatment status of tirabrutinib in relapsed or refractory pcnsl (ROSETTA)Relapsed or refractory Primary CNS LymphomaPrimary CNS lymphomaD008228JPRN-jRCT1021230006agane Motoo206
Recruiting
Not Applicable
The study on prognosis in patients with fatty liverJPRN-UMIN000046497Yokohama City University3,000